ducovest

SPXV:ARCA-ProShares S&P 500 Ex-Health Care (USD)

ETF | Large Blend | NYSE Arca

Last Closing

USD 111.3072

Change

+0.28 (+0.25)%

Market Cap

USD 1.15M

Volume

308.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results, before fees and expenses that track the performance of the S&P 500? Ex-Health Care Index (the "index"). Under normal circumstances, the fund will invest at least 80% of its total assets in component securities. The index seeks to provide exposure to the companies of the S&P 500? Index (the "S&P 500?") with the exception of those companies included in the Health Care Sector.

Company Website : www.proshares.com

Currency: USD

Country : USA

Inception Date: 22/09/2015

Primary Benchmark: S&P 500 Ex-Health Care USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.27%

Management Expense Ratio: 0.27 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Large Blend

Symbol Name Mer Price(Change) Market Cap
VTI Vanguard Total Stock Market In.. 0.03 %

N/A

 USD 1,599.41B
SPY SPDR S&P 500 ETF Trust 0.09 %

N/A

 USD 528.58B
IVV iShares Core S&P 500 ETF 0.04 %

N/A

 USD 428.78B
VOO Vanguard S&P 500 ETF 0.03 %

N/A

 USD 419.07B
VIG Vanguard Dividend Appreciation.. 0.06 %

N/A

 USD 77.60B
RSP Invesco S&P 500® Equal Weight.. 0.20 %

N/A

 USD 53.38B
ITOT iShares Core S&P Total U.S. St.. 0.03 %

N/A

 USD 51.22B
SCHX Schwab U.S. Large-Cap ETF 0.03 %

N/A

 USD 40.18B
IWB iShares Russell 1000 ETF 0.15 %

N/A

 USD 33.43B
VV Vanguard Large-Cap Index Fund .. 0.04 %

N/A

 USD 32.71B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.61% 79% B- 77% C+
Dividend Return 0.29% 31% F 16% F
Total Return 10.90% 78% C+ 76% C+
Trailing 12 Months  
Capital Gain 32.38% 88% B+ 82% B
Dividend Return 1.52% 46% F 21% F
Total Return 33.90% 86% B+ 81% B-
Trailing 5 Years  
Capital Gain 89.13% 87% B+ 83% B
Dividend Return 8.76% 69% C- 33% F
Total Return 97.89% 87% B+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 12.39% 81% B- 78% C+
Dividend Return 13.71% 83% B 76% C+
Total Return 1.32% 68% D+ 33% F
Risk Return Profile  
Volatility (Standard Deviation) 19.46% 36% F 58% F
Risk Adjusted Return 70.44% 67% D+ 92% A
Market Capitalization 1.15M 5% F 10% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.